Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure.
de Bakker M, Petersen TB, Akkerhuis KM, Harakalova M, Umans VA, Germans T, Caliskan K, Katsikis PD, van der Spek PJ, Suthahar N, de Boer RA, Rizopoulos D, Asselbergs FW, Boersma E, Kardys I. de Bakker M, et al. Among authors: akkerhuis km. Biol Sex Differ. 2023 May 17;14(1):29. doi: 10.1186/s13293-023-00516-9. Biol Sex Differ. 2023. PMID: 37198662 Free PMC article.
Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial.
Ariotti S, van Leeuwen M, Brugaletta S, Leonardi S, Akkerhuis KM, Rexhaj E, Janssens G, Ortega-Paz L, Rizzotti D, van den Berge JC, Heg D, Francolini G, Windecker S, Valgimigli M; HI-TECH Investigators. Ariotti S, et al. Among authors: akkerhuis km. Am Heart J. 2017 Jul;189:128-136. doi: 10.1016/j.ahj.2017.03.017. Epub 2017 Mar 29. Am Heart J. 2017. PMID: 28625369 Clinical Trial.
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.
Brugts JJ, Isaacs A, de Maat MP, Boersma E, van Duijn CM, Akkerhuis KM, Uitterlinden AG, Witteman JC, Cambien F, Ceconi C, Remme W, Bertrand M, Ninomiya T, Harrap S, Chalmers J, Macmahon S, Fox K, Ferrari R, Simoons ML, Danser AJ. Brugts JJ, et al. Among authors: akkerhuis km. J Hypertens. 2011 Mar;29(3):509-19. doi: 10.1097/HJH.0b013e328341d117. J Hypertens. 2011. PMID: 21157371
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
Oemrawsingh RM, Lenderink T, Akkerhuis KM, Heeschen C, Baldus S, Fichtlscherer S, Hamm CW, Simoons ML, Boersma E; CAPTURE investigators. Oemrawsingh RM, et al. Among authors: akkerhuis km. Heart. 2011 Jul;97(13):1061-6. doi: 10.1136/hrt.2010.197392. Epub 2011 May 10. Heart. 2011. PMID: 21558475
Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock.
Marcolino MS, Simsek C, de Boer SP, van Domburg RT, van Geuns RJ, de Jaegere P, Akkerhuis KM, Daemen J, Serruys PW, Boersma E. Marcolino MS, et al. Among authors: akkerhuis km. Cardiology. 2012;121(1):47-55. doi: 10.1159/000336154. Epub 2012 Mar 1. Cardiology. 2012. PMID: 22378251
134 results